Pharmaceutical Executive
The key steps to evading automation-fueled data crises.
Emily Eller and Kevin Frymire
Advertisement
Emily Eller and Kevin Frymire are Associate Partners at Beghou Consulting.
Articles by Emily Eller and Kevin Frymire
Automation is an essential aspect of data management and processing today in the pharma industry. At the same time, it’s important for companies to strike a balance between humans and machines, write Emily Eller and Kevin Frymire.
Advertisement
Latest Updated Articles
- Pharma Automation: Avoiding the Dangers
July 26th 2019
Pharma Automation: Avoiding the DangersOctober 1st 2019
Advertisement
Advertisement
Trending on PharmExec
1
Bayer Shares Briefly Dip After Activist Investor Offloads Millions of Dollars in Company Stock
2
Pharmaceutical Executive Daily: FDA Issues Warning Letter to ImmunityBio
3
Pharma M&A Roundup: Merck to Acquire Terns Pharmaceuticals, Shionogi to Acquire 50% of Apnimed’s Ownership of Shionogi-Apnimed Sleep Science
4
FDA Sends Warning Letter to ImmunityBio for Misleading Claims in Advertisement
5